Skip to content

The effect of low-dose volatile anesthetics on intraoperative evoked potential monitoring during anesthesia using remimazolam: a randomized controlled trial

The effect of low-dose volatile anesthetics on intraoperative evoked potential monitoring during anesthesia using remimazolam: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007534
Enrollment
40
Registered
2022-07-21
Start date
2023-01-05
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Each two group will be designated as Desflurane and Sevoflurane. The infusion of volatile anesthetics will be started at the end of main surgical procedure (T1). The change of evoked potential

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria - American Society of Anesthesiologists physical status I~III - 20 years old = Age < 80 years old - Patients who are scheduled for elective cervical spine operation with intraoperative evoked potentials monitoring - Patients who received written informed consent

Exclusion criteria

Exclusion criteria: Exclusion criteria - Patients with tolerance or hypersensitivity to benzodiazepine - Patients with dependence or addiction to psychotropic drugs or alcohol - Patients with previous brain-related neurosurgery - Patients with inserted status of intracranial device - Pregnant and lactating women - Patients with pacemaker insertion which may interfere evoked potentials test - Patients with acute narrow angle glaucoma - Patients with moderate hypersensitivity to Dextran40 - Patients with history of malignant hyperthermia or having genetic susceptible malignant hyperthermia - Previous hypersensitivity history to halogenated inhalation agents

Design outcomes

Primary

MeasureTime frame
The change of amplitude and latency of evoked potentials exam

Secondary

MeasureTime frame
The change of amplitude and latency of evoked potentials exam

Countries

Korea, Republic of

Contacts

Public ContactHeesun Park

Asan Medical Center

lenadiar@naver.com+82-2-3010-0649

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026